Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantASTRAZENECA SINGAPORE PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
INTRAVENOUS
Medical Information
Pending
Manufacturer Information
ASTRAZENECA SINGAPORE PTE LTD
Baxter Oncology GmbH
Active Ingredients
Documents
Package Inserts
Datroway PI May 2025.pdf
Approved: May 10, 2025